|27.40||+0.37 / +1.37%|
Data as of 4:02pm ET
|27.40||0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 31.00, with a high estimate of 33.00 and a low estimate of 21.00. The median estimate represents a +13.14% increase from the last price of 27.40.
The current consensus among 8 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.